Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 59
Filter
1.
Front Cardiovasc Med ; 11: 1348341, 2024.
Article in English | MEDLINE | ID: mdl-38516003

ABSTRACT

Objective: Fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) are invasive methods to assess the functional significance of intermediate severity coronary lesions. Both indexes have been extensively validated in clinical trials in guiding revascularisation in patients with stable ischaemic heart disease undergoing percutaneous coronary intervention (PCI) with improved clinical outcomes. However, the role of these tools in coronary artery bypass grafting (CABG) is less clear. Methods: A meta-analysis of randomised trials and observational studies was carried out to help in determining the optimal strategy for assessing lesion severity and selecting graft targets in patients undergoing CABG. Electronic searches were carried out on Embase, MEDLINE, and Web of Science. A group of four authors independently screened and then assessed the retrieved records. Cochrane's Risk of Bias and Robins-I tools were used for bias assessment. A survey was conducted among surgeons and cardiologists to describe current attitudes towards the preoperative use of functional coronary investigations in practice. Results: Clinical outcomes including mortality at 30 days, perioperative myocardial infarction, number of grafts, incidence of stroke, rate of further need for revascularisation, and patient-reported quality of life did not differ in CABG guided by functional testing from those guided by traditional angiography.The survey revealed that in half of the surgical and cardiology units functional assessment is performed in CABG patients; there is a general perception that functional testing has improved patient care and its use would clarify the role of moderate coronary lesions that often need multidisciplinary rediscussions; moderate stenosis are felt to be clinically relevant; and anatomical considerations need to be taken into account together with functional assessment. Conclusions: At present, the evidence to support the routine use of functional testing in intermediate lesions for planning CABG is currently insufficient. The pooled data currently available do not show an increased risk in mortality, myocardial injury, and stroke in the FFR/iFR-guided group. Further trials with highly selected populations are needed to clarify the best strategy. Systematic Review Registration: ClinicalTrials.gov, identifier (CRD42023414604).

2.
Ann R Coll Surg Engl ; 106(3): 226-236, 2024 Mar.
Article in English | MEDLINE | ID: mdl-37642088

ABSTRACT

INTRODUCTION: There is a paucity of data on the optimal management of oesophagopleural fistula (OPF) following pneumonectomy. The current published literature is limited to case reports and small case series. Although rare, OPF can have a significant impact on both the morbidity and mortality of patients. METHODS: Two cases of OPF managed at our institution were reported. A systematic review was then conducted in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance concerning OPF following pneumonectomy. Demographic, operative and management data were analysed. FINDINGS: Systematic review-identified data pertaining to 59 patients from 31 papers was collated. Median patient age was 59.5 years with pneumonectomy performed typically for malignancy (68%) or tuberculosis (19%). Median time from pneumonectomy to a diagnosis of OPF was 12.5 months. Twenty-five per cent of the patients had a synchronous bronchopleural fistula. Management of OPF in this setting is heterogenous. Conservative management was often reserved for asymptomatic or unfit patients. The remainder underwent endoscopic or surgical correction of the fistulae or a combination of the two with varying outcomes. Median follow-up was 18 months. All-cause mortality was 31% (18/59) with a median duration from pneumonectomy to death of 35 days (range 1-1,095). CONCLUSIONS: Major heterogeneity of management for this rare complication hinders the introduction of standardised guidance of post-pneumonectomy OPF. Surgical and endoscopic intervention is feasible and can be successful in specialist centres. Adopting an multidisciplinary team approach involving both oesophagogastric and thoracic surgery teams and the introduction of a registry database of postoperative complications are likely to yield optimal outcomes.


Subject(s)
Fistula , Pneumonectomy , Humans , Conservative Treatment , Databases, Factual , Pneumonectomy/adverse effects , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Postoperative Complications/therapy
3.
Ann R Coll Surg Engl ; 104(5): 373-379, 2022 May.
Article in English | MEDLINE | ID: mdl-34939856

ABSTRACT

INTRODUCTION: Acute scrotal pain is a common paediatric surgical emergency. Assessment and timely exploration are required to rule out testicular torsion (TT) and prevent unnecessary morbidity. METHODS: A retrospective observational cohort study was carried out at two district general hospitals in the UK for boys aged ≤16 years presenting with acute scrotal pain between January 2014 and October 2017 managed by adult general surgery (AGS) at one hospital and adult urology (AU) at the other. RESULTS: Some 565 patients were eligible for inclusion (n=364 AGS, n=201 AU). A higher proportion of patients underwent surgical exploration at AGS compared with AU (277/346 (80.1%) vs 96/201 (47.8%); p<0.001). Of those who underwent exploration, 101/373 (27.1%) had TT, of whom 25/101 (24.8%) underwent orchidectomy and 125/373 (33.5%) had torted testicular appendage. There was no statistically significant difference in rates of orchidectomy between AGS (19/68, 27.9%) and AU (6/33, 18.2%) with testicular salvage rates of 72.1% and 81.8%, respectively (p=0.334). Patients were twice as likely to be readmitted at AGS as at AU (28/346 (8.1%) vs 8/201 (4.0%); p=0.073). CONCLUSION: Although intraoperative findings were similar between adult general surgeons and urologists, there were significant differences in surgical management, with a higher rate of surgical exploration by general surgeons. Testicular salvage and 30-day postoperative morbidity rates at both institutions were acceptable but the readmission rate was high at 6.6%. It is not known why there is a heterogeneity in management of acute scrotal pain between specialist centres, and further prospective investigations are warranted.


Subject(s)
Genital Diseases, Male , Skin Diseases , Spermatic Cord Torsion , Surgeons , Adult , Child , Humans , Male , Pain , Retrospective Studies , Scrotum/surgery , Spermatic Cord Torsion/diagnosis , Spermatic Cord Torsion/surgery , United Kingdom/epidemiology , Urologists
7.
Br J Dermatol ; 162(2): 397-403, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-19804592

ABSTRACT

BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin condition that is characterized by a defective skin barrier. Despite the well-recognized role of proteases in skin barrier maintenance, relatively little is known of the contribution made by matrix metalloproteinases (MMPs) to the inflammatory process in AD. OBJECTIVES: To test a simple, novel ex vivo bioassay technique in an analysis of the MMPs present in wash samples taken from the skin surface of patients with AD. METHODS: Saline wash samples were collected from eczematous and unaffected areas of the skin of patients with AD and from the skin of normal controls. Wash samples were analysed for their MMP content using a functional peptide cleavage assay, gelatin zymography and an antibody array. RESULTS: Using a functional substrate cleavage assay, skin wash samples from AD lesions were shown to contain 10- to 24-fold more MMP activity than those from normal control skin (P < 0.02) and fivefold more than those from unaffected AD skin (P < 0.05); this activity was inhibited by a broad-spectrum MMP inhibitor Ro 31-9790. Gelatin zymography and antibody array analysis revealed substantial levels of MMP-8 (neutrophil collagenase) and MMP-9 (92-kDa gelatinase) in AD skin wash samples as well as lower levels of MMP-10 (stromelysin 2) and tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2; low levels of MMP-1 (fibroblast collagenase), MMP-3 (stromelysin 1) and TIMP-4 were also detected. CONCLUSIONS: A simple skin wash technique suitable for the quantitative and functional analysis of biomolecules in AD is described. Using this method we show that MMPs, and in particular MMP-8 and MMP-9, represent an important potential component of the pathology of AD. The method is expected to prove useful in advancing our understanding of AD and in identifying biomarkers for the evaluation of new therapies.


Subject(s)
Dermatitis, Atopic/metabolism , Matrix Metalloproteinases/metabolism , Skin/metabolism , Adolescent , Biomarkers/analysis , Biomarkers/metabolism , Case-Control Studies , Child , Child, Preschool , Humans , Matrix Metalloproteinases/analysis , Severity of Illness Index , Skin/pathology , Skin Tests/methods , Tissue Inhibitor of Metalloproteinases/analysis , Tissue Inhibitor of Metalloproteinases/metabolism
9.
Inflamm Res ; 50(8): 400-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11556520

ABSTRACT

OBJECTIVE AND DESIGN: We have evaluated the effects of the broad-spectrum cysteine protease inhibitor E64 on allergic lung inflammation in the mouse ovalbumin model of human asthma. We have also characterised membrane-associated cathepsin enzyme activity on a range of cell types. MATERIALS: Balb/C mice, E64 and CA074, various cell lines. TREATMENT: E64 was administered by subcutaneous minipump into ovalbumin-sensitised mice prior to intranasal ovalbumin challenge. The effect of E64 on ovalbumin-induced inflammation in vivo and ovalbumin-specific T cell proliferation in vitro and ex vivo was examined. Membrane-associated cathepsin activity on various cell types was measured. RESULTS: E64 treatment (0.36-0.48 mg/day) led to a significant reduction in eosinophil numbers and lung weights in the mouse model. Histological examination of lungs confirmed the anti-inflammatory effect. E64 greatly reduced ovalbumin-specific T cell numbers in the lymph nodes draining the lung following intranasal challenge whilst an accumulation of these T cells was found in the 'priming' lymph nodes. An analysis of various cells involved in lymphocyte priming and migration revealed that monocytes, dendritic cells and endothelial cells express high levels of membrane-associated cathepsin B activity. CONCLUSIONS: Since E64 is not cell permeable and does not inhibit antigen-induced T cell proliferation in vitro or in vivo, the data indicate that membrane-associated cysteine proteases, possibly cathepsin B, may regulate T lymphocyte migration in vivo.


Subject(s)
Allergens/pharmacology , Cysteine Proteinase Inhibitors/therapeutic use , Pneumonia/drug therapy , T-Lymphocytes/drug effects , Animals , Cathepsin B/metabolism , Cell Division/drug effects , Cell Line , Cell Membrane/metabolism , Cell Movement/drug effects , Extracellular Space/metabolism , Female , Hematopoietic Stem Cells/drug effects , Leucine/analogs & derivatives , Leucine/therapeutic use , Lung/enzymology , Lung/pathology , Lymphocyte Activation/drug effects , Mice , Mice, Inbred BALB C , Ovalbumin/immunology , Pneumonia/immunology , Pneumonia/pathology
10.
Eur J Immunol ; 31(2): 440-9, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11180108

ABSTRACT

Engineered MHC-peptide targets capable of inducing recognition by CTL may prove useful in designing vaccines for infectious disease and cancer. We tested whether peptides directly linked to beta2-microglobulin (beta2m) could complex with human HLA class I heavy chain, and could be recognized by human CTL, both as soluble reagents and as cell surface constituents. An HLA-A2-restricted peptide epitope was physically linked to the N terminus of human beta2m. This fusion protein refolded efficiently in vitro with HLA-A2 heavy chain, and when multimerized, the resultant complexes ("fusamers") bound specifically to appropriate CTL clones. These fused peptide/MHC complexes were as efficient as standard tetrameric peptide/MHC complexes in recognizing antigen-specific CTL. When the fusion protein was delivered to target cells using a retroviral vector, these cells were recognized and killed by appropriate CTL clones. Efficient sensitization to CTL lysis was achieved in TAP-negative and beta2m-negative cell lines, as well as in unmutated B cell lines, proving that such constructs may be effective in inducing CTL even when the MHC class I pathway has been disrupted. Specific peptides covalently linked to beta2m and delivered via retroviral vectors may be useful reagents for in vivo priming of CTL against epitopes of clinical relevance.


Subject(s)
Antigen Presentation , Histocompatibility Antigens Class I/physiology , Neoplasms/therapy , Recombinant Fusion Proteins/immunology , T-Lymphocytes, Cytotoxic/immunology , beta 2-Microglobulin/immunology , Cell Line , Cytotoxicity, Immunologic , Genetic Therapy , Histocompatibility Antigens Class I/chemistry , Humans , Neoplasms/immunology , Retroviridae/genetics , beta 2-Microglobulin/genetics
11.
Vaccine ; 18(17): 1863-9, 2000 Mar 06.
Article in English | MEDLINE | ID: mdl-10699335

ABSTRACT

We characterized the immunogenicity of the hybrid Ty-virus-like carrying the CD8(+) T cell epitope (SYVPSAEQI) of the circumsporozoite (CS) protein of Plasmodium yoelii (TyCS-VLP), a rodent malaria parasite. Balb/c mice were immunized with hybrid TyCS-VLP, and their CS-specific CD8(+) T cell response was quantitatively evaluated with the ELISPOT assay, based on the enumeration of epitope specific gamma-interferon secreting CD8(+) T cell. A single immunization with the TyCS-VLP by a variety of routes and doses indicated that the maximal response occurred in mice, which were immunized with 50 micrograms of these particles, administered via intramuscular. Combined immunization of mice with this TyCS-VLP followed by recombinant vaccinia virus expressing the entire P. yoelii CS protein (VacPyCS) or irradiated sporozoites, induced high levels of IFN-gamma-producing cells. The immunization regime, priming with TyCS-VLP and boosting with VacPyCS generated a potent protective immune response, which strongly inhibited P. yoelii liver stages development and protected 62% of the mice against a subsequent live P. yoelii sporozoite challenge.


Subject(s)
Antigens, Protozoan/immunology , Malaria Vaccines/immunology , Malaria/prevention & control , Plasmodium yoelii/immunology , Protozoan Proteins/immunology , Retroelements/immunology , Vaccinia virus/immunology , Animals , Antigens, Protozoan/genetics , CD8-Positive T-Lymphocytes/immunology , Dose-Response Relationship, Immunologic , Drug Administration Routes , Epitopes/genetics , Epitopes/immunology , Female , Immunization, Secondary , Immunologic Memory , Interferon-gamma/biosynthesis , Liver/immunology , Liver/metabolism , Liver/parasitology , Malaria/immunology , Malaria Vaccines/administration & dosage , Malaria Vaccines/genetics , Mice , Mice, Inbred BALB C , Plasmodium yoelii/genetics , Plasmodium yoelii/growth & development , Protozoan Proteins/genetics , RNA, Ribosomal/biosynthesis , Retroelements/genetics , Spleen/cytology , Spleen/immunology , Spleen/metabolism , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunology , Vaccinia virus/genetics
12.
Vaccine ; 18(15): 1506-14, 2000 Feb 14.
Article in English | MEDLINE | ID: mdl-10618548

ABSTRACT

In this study we constructed a plasmid containing the gene encoding varicella-zoster virus transmembrane glycoprotein gE (VZV gE) and evaluated its utility for DNA immunization in mice. Our initial work demonstrates that intramuscular and subcutaneous injection of VZV gE DNA, without the use of costimulatory molecules or other adjuvant materials, results in the generation of antigen-specific antibodies of primarily the IgG2a subclass, indicating that this vaccine can stimulate Th1 type immunity. This is the first report of a prototype DNA vaccine for varicella-zoster virus.


Subject(s)
Herpesvirus 3, Human/immunology , Vaccines, DNA/immunology , Viral Envelope Proteins/genetics , Viral Vaccines/immunology , Animals , Antibodies, Viral/blood , Immunoglobulin G/classification , Injections, Intramuscular , Injections, Subcutaneous , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Plasmids , Vaccines, DNA/administration & dosage , Viral Envelope Proteins/immunology , Viral Vaccines/administration & dosage
13.
Int Immunol ; 11(12): 1927-34, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10590258

ABSTRACT

It has been previously demonstrated that hybrid Ty virus-like particles (VLP) prime effective CD8(+) and CD4(+) T cell responses. In this study, we investigated the effect of treating mice with Ty VLP carrying the immunodominant epitope of Der p 1 after sensitizing them to the group 1 allergen of the house dust mite Dermatophagoides pteronyssinus (Der p 1), under conditions that induce T(h)2 immunity. We show that i.p. treatment with the hybrid VLP abrogated allergen-specific IL-5 production and reduced allergen-specific cell proliferation. This suppression of the response was mediated by CD4(+) T cells and was not accompanied by an increase in IFN-gamma production.


Subject(s)
Allergens/immunology , CD4-Positive T-Lymphocytes/physiology , Epitopes, T-Lymphocyte , Glycoproteins/immunology , Immunodominant Epitopes/immunology , Interferon-gamma/biosynthesis , Interleukin-5/biosynthesis , Animals , Antigens, Dermatophagoides , Cells, Cultured , Down-Regulation , Female , Lymphocyte Activation , Mice , Mice, Inbred C57BL , Mites/immunology , Peptide Fragments/pharmacology
14.
J Med Virol ; 59(1): 78-83, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10440812

ABSTRACT

Yeast Ty virus-like particles (VLPs) containing viral protein inserts have previously been shown to be potent immunogens, inducing both humoral and cell mediated immunity (CMI). The antigenicity of hybrid VLPs containing fragments of the varicella-zoster virus (VZV) gE protein or the assembly protein (AP) was assessed by lymphocyte proliferation. Peripheral blood mononuclear cells (PBMCs) from patients with a recent natural VZV infection were stimulated in vitro with VZV-VLPs together with control antigens. PBMC samples from both varicella (85%) and zoster (75%) patients proliferated in responses to at least one of the gE VZV-VLPs. As reported for the first time, VZV specific lymphocyte responses were also identified towards the VZV AP in two varicella and two zoster patient samples. The results demonstrate specific CMI recognition of the VZV gE fragments tested and the VZV AP delivered in the form of recombinant Ty-VLPs, and highlights their potential use as a recombinant antigen delivery system for vaccination.


Subject(s)
Herpesvirus 3, Human/immunology , T-Lymphocytes/immunology , Viral Envelope Proteins/immunology , Viral Proteins/immunology , Virion/immunology , Adult , Antigens, Viral/immunology , Chickenpox/immunology , DNA Transposable Elements/genetics , Herpes Zoster/immunology , Herpesvirus 3, Human/chemistry , Humans , Lymphocyte Activation , Middle Aged , Vaccines, Synthetic/immunology , Viral Envelope Proteins/genetics , Viral Proteins/genetics , Virion/genetics , Virus Assembly , Yeasts/genetics
15.
J Gen Virol ; 80 ( Pt 4): 1025-1033, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10211973

ABSTRACT

Human papillomavirus type 6 (HPV-6) is the causative agent of condyloma acuminata, a common sexually transmitted disease. Virus-like particles (VLPs) assembled from the L1 major capsid protein represent promising candidates for prophylactic vaccines. However, any intratype sequence variation among HPV-6 L1 ORFs will influence which sequence is used for a vaccine according to its prevalence in the population and its propensity for VLP production. Therefore, we have analysed the entire L1 nucleotide sequence of 17 clinical isolates of HPV-6 from the London area. We found 28 positions where changes from the prototype HPV-6b L1 occurred, showing that HPV-6 L1 intratype variation is greater than previously reported. The most frequently observed substitutions are clustered into three discrete regions: R1 (nt 5920-6075), R2 (nt 6590-6670) and R3 (nt 7070-7230). Indeed, most of the nucleotide substitutions within the HPV-6 L1 reported worldwide also map to these regions. The R3 region contains predominantly non-silent substitutions, the most common of which is a G-to-C substitution at position 7079. This results in a Glu-to-Gln change at aa 431, although this change had no effect on VLP yield or stability. This substitution defines a new HPV-6 L1 amino acid sequence that is more abundant in the isolates examined than any other reported sequence.


Subject(s)
Capsid/genetics , Mutation , Open Reading Frames , Papillomaviridae/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , Humans , Molecular Sequence Data , Virion/physiology
16.
Eur J Immunol ; 28(12): 4345-55, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9862371

ABSTRACT

The desirability of inducing cytotoxic T cell responses to defined epitopes in humans has led to the development of a variety of recombinant delivery systems. Recombinant protein particles derived from a yeast retrotransposon (Ty) and the modified Ankara vaccinia (MVA) virus can deliver large epitope strings or even whole proteins. Both have previously been administered safely in humans. Immunization with recombinant Ty and MVA containing a single Plasmodium berghei class I-binding epitope provided 95% sterile protection against malaria in mice. The sequence of immunization, Ty followed by MVA, was critical to elicit high levels of IFN-gamma-producing cells and protection. The reciprocal sequence (MVA/TY) or homologous boosting was not protective. Both constructs (Ty and MVA) contain the H-2Kd-restricted pb9 CTL epitope from the circumsporozoite protein of P. berghei among a string of 8-15 human P. falciparum-derived CTL epitopes restricted through 7 common HLA alleles as well as widely recognized CD4 T cell epitopes. Thus, the novel recombinant Ty/MVA prime/boost combination with these constructs provides a safe alternative for evaluation for human vaccination against P. falciparum malaria.


Subject(s)
Antigens, Protozoan/immunology , Drug Delivery Systems , Histocompatibility Antigens Class I/immunology , Malaria Vaccines , Malaria/immunology , Plasmodium berghei/immunology , T-Lymphocytes/immunology , Animals , Cytotoxicity, Immunologic , Humans , Malaria/prevention & control , Mice , Recombinant Proteins/genetics , Recombinant Proteins/immunology
17.
Br J Clin Pharmacol ; 46(1): 83-6, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9690954

ABSTRACT

AIMS: The potential effects of food and gender on the pharmacokinetics of tucaresol were investigated in healthy volunteers. METHODS: Ten males (mean weight 76.5 kg, age 27-42 years) and eight females (mean weight 58.9 kg, age 18-44 years) received a single oral dose of 200 mg tucaresol on two occasions in random order. On one occasion, tucaresol was given after an overnight fast and on the other, immediately after ingestion of a standard breakfast. RESULTS: There were no significant differences in standard pharmacokinetic parameters between the two occasions but the rate of tucaresol absorption was faster after food intake. Female subjects had higher Cmax (ratio 1.25 with 95% CI 1.10-1.44) and AUC (ratio 1.25 with 95% CI 1.05-1.49) values than males but the differences were due to the higher body weights of the males; weight-adjusted apparent total clearance values (CL/F) were not different between genders (ratio 1.03 with 95% CI 0.87-1.21). CONCLUSIONS: Food intake and gender have no significant effect on the exposure to orally administered tucaresol.


Subject(s)
Benzaldehydes/pharmacokinetics , Benzoates/pharmacokinetics , Food , Absorption , Administration, Oral , Adolescent , Adult , Female , Humans , Male , Sex Factors
18.
Clin Pharmacol Ther ; 63(3): 342-53, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9542478

ABSTRACT

OBJECTIVE: Zolmitriptan is a selective 5HT1B/1D-agonist for the treatment of migraine. In this study we investigated the cardiovascular and central nervous system effects and the pharmacokinetics of zolmitriptan in young and elderly adults. METHODS: Twelve young adult and 12 elderly volunteers received single doses of 5, 10, and 15 mg zolmitriptan during a randomized, double-blind, placebo-controlled study. Blood pressure, heart rate, ECG, and central nervous system effects were monitored, and pharmacokinetic parameters of zolmitriptan and its metabolites calculated. RESULTS: Zolmitriptan did not affect heart rate and had little effect on systolic blood pressure in the young adults. In the elderly, mean peak supine systolic blood pressure values were 9 to 16 mm Hg higher after zolmitriptan than after placebo. Mean peak diastolic pressure was 6 to 10 mm Hg higher in both age groups. These changes were transient. Postural changes in blood pressure were unaffected. There was a dose-related increase in sedation, but the magnitude of the effects was small. Mean observed peak plasma concentration (Cmax) and area under the plasma concentration-time profile [AUC(0-infinity)] for zolmitriptan and its active N-desmethyl metabolite were similar in both age groups but higher in young women than in young men. Metabolite/parent ratios probably the result of greater first-pass metabolism in young men. Zolmitriptan half-life was 2.8 to 3.6 hours in the elderly compared with 2.7 to 2.9 hours in young adults. Mean Cmax and AUC(0-infinity) for the inactive, N-oxide, and the indole acetic acid metabolites were higher in the elderly, associated with lower renal clearance. CONCLUSIONS: Zolmitriptan was well tolerated, with an effect of age on its effects on blood pressure and the pharmacokinetics of its metabolites. The data suggest no need for dose adjustment for age. In young subjects, concentrations were higher in women than in men, but the differences were insufficient to justify dosage adjustment.


Subject(s)
Oxazoles/pharmacology , Oxazolidinones , Serotonin Receptor Agonists/pharmacology , Adult , Age Factors , Aged , Blood Pressure/drug effects , Central Nervous System/drug effects , Double-Blind Method , Electrocardiography/drug effects , Female , Half-Life , Heart Rate/drug effects , Humans , Male , Oxazoles/pharmacokinetics , Reference Values , Serotonin Receptor Agonists/pharmacokinetics , Sex Factors , Tryptamines
19.
Br J Clin Pharmacol ; 45(1): 87-9, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9489600

ABSTRACT

AIMS: Changes in both digoxin and aciclovir renal clearance following coadministration with some other renally eliminated drugs have been reported. The potential interaction of valaciclovir, with its antiherpetic metabolite aciclovir, and digoxin was investigated. METHODS: Twelve healthy volunteers (seven males, five females) participated in an open, randomized, four-period crossover study. Valaciclovir, 1000 mg, was given alone on one occasion, and on another, after the second of two 0.75 mg digoxin doses administered 12 h apart. Blood samples and all urine were collected up to 12 h following the valaciclovir dose for aciclovir radioimmunoassay. On a third occasion, digoxin was given alone and on a fourth, with 1000 mg valaciclovir three times/day for 8 days starting 12 h before the first digoxin dose. Blood samples were taken up to 168 h and all urine collected up to 24 h following the second dose for digoxin radioimmunoassay. RESULTS: There were no clinically significant differences in digoxin or aciclovir pharmacokinetic parameters when digoxin or valaciclovir was given alone or in combination. CONCLUSIONS: No dosage adjustment is required when valaciclovir and digoxin are coadministered.


Subject(s)
Acyclovir/analogs & derivatives , Antiviral Agents/pharmacokinetics , Cardiotonic Agents/pharmacokinetics , Digoxin/pharmacokinetics , Prodrugs/pharmacokinetics , Valine/analogs & derivatives , Acyclovir/adverse effects , Acyclovir/pharmacokinetics , Adult , Antiviral Agents/adverse effects , Cardiotonic Agents/adverse effects , Cross-Over Studies , Digoxin/adverse effects , Drug Administration Schedule , Drug Interactions , Female , Humans , Male , Prodrugs/adverse effects , Valacyclovir , Valine/adverse effects , Valine/pharmacokinetics
20.
Nat Biotechnol ; 15(12): 1280-4, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9359112

ABSTRACT

Ty virus-like particles consist of a single protein species that can be produced in yeast. Recombinant Ty-VLPs carrying a string of up to 15 defined cytotoxic T lymphocyte (CTL) epitopes from Plasmodium species prime protective CTL responses in mice following a single administration without adjuvant. Effective processing of epitopes from the string was demonstrated in vitro and in vivo and was not affected by flanking sequences.


Subject(s)
Epitopes/chemistry , Malaria Vaccines/chemistry , Plasmodium falciparum/immunology , Amino Acid Sequence , Animals , Epitopes/immunology , Female , Humans , Malaria Vaccines/immunology , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Plasmodium berghei/immunology , T-Lymphocytes, Cytotoxic/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...